HC Wainwright & Co. Initiates Coverage On ImageneBio with Buy Rating, Announces Price Target of $28

Benzinga Newsdesk www.benzinga.com Neutral 72.0%

Neg 0% Neu 72% Pos 0%

HC Wainwright & Co. analyst Arthur He initiates coverage on ImageneBio (NASDAQ:IMA) with a Buy rating and announces Price Target of $28.